MAPK3 and metabolic disease: Kinase suppressor of Ras 1 has been reported to attenuate neurostatin secretion and extracellular signal-regulated kinase 1 and 2 signaling in human endocrine cells, thereby participating in obesity-related metabolic disorders and Ras-driven cancer (55).